Read More Pharma Industry News Can the BACKBEAT trial validate a new category of device-driven hypertension therapy? What does the BACKBEAT trial mean for Medtronic plc and Orchestra BioMed Holdings, Inc.? Discover the future of device-driven hypertension therapy. bySoujanya RaviMay 3, 2026